We are live on ! Find out more
SRXH

SRX Global

19 hedge funds and large institutions have $2.55M invested in SRX Global in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% less ownership

Funds ownership: 0.01%0.01% (-0%)

14% less funds holding

Funds holding: 2219 (-3)

27% less capital invested

Capital invested by funds: $3.47M → $2.55M (-$920K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
19
Holders Change
-3
Holders Change %
-13.64%
% of All Funds
0.3%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
Increased
3
Reduced
2
Closed
3
Calls
Puts
Net Calls
Net Calls Change

SRXH Hedge Fund Activity: Q1 2023 in Review

19 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in SRX Global (SRXH) for Q1 2023, worth a combined $2.55M — down 27% from $3.47M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of SRXH and 0 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 3 added.

The largest buyer was Brown Brothers Harriman & Co, adding an estimated $111K. The largest seller was Must Asset Management, cutting an estimated $29.3K.

  • 19 institutional investors held SRX Global (SRXH) as of Q1 2023, down from 22 in Q4 2022.
  • Funds reported $2.55M of SRX Global stock for Q1 2023, down 27% quarter-over-quarter.
  • 0 funds opened new SRX Global positions in Q1 2023 and 3 closed out, a net change of -3 holders.
  • The largest SRX Global buyer in Q1 2023 was Brown Brothers Harriman & Co, an estimated $111K added.
  • The largest SRX Global seller in Q1 2023 was Must Asset Management, an estimated $29.3K sold.

Based on aggregated 13F filings for Q1 2023.